发布时间:2020-04-01 13:34 原文链接: 欧盟发布2019年11月—2020年3月禽流感概述

  2019年11月16日至2020年2月15日,欧盟报告了36起高致病性禽流感(HPAI) A(H5N8)疫情。在报告所述期间,有两例人类感染甲型(H9N2)病毒的病例。部分原文报道如下:

1.jpg

  Between 16 November 2019 and 15 February 2020, 36 highly pathogenic avian influenza (HPAI) A(H5N8) virus outbreakswere reported in Europe in poultry (n=34), captive birds (n=1) and wild birds (n=2), in Poland, Hungary, Slovakia, Romania, Germany, Czechiaand Ukraine,one HPAI outbreakcaused by a simultaneous infection with A(H5N2) and A(H5N8) was reported in poultry in Bulgaria, andtwo low pathogenic avian influenza (LPAI) A(H5) virus outbreaks were reported in poultryin the United Kingdom and in Denmark. Genomic characterisation of the HPAI A(H5N8) viruses suggests that they are reassortants of HPAI A(H5N8) viruses from Africa and LPAI viruses from Eurasia. It is likely that this reassortment occurred in wild migratory birds in Asia during the summer and then spread to eastern Europe with the autumnmigration. This is the first time that wild bird migration from Africa to Eurasia has been implicated in the long‐distance spread of HPAI viruses to the EU. Given the late incursion of HPAI A(H5N8) virus into the EU in this winter season (first outbreak reported on 30 December 2019), its overall restriction to eastern Europe, and the approaching spring migration, the risk of the virus spreadingfurther in the west via wild birds is decreasing for the coming months. Genetic analysis of the HPAI A(H5N2) and A(H5N8) viruses detected in the Bulgarian outbreak reveals that these virusesare both related to the 2018‐19 Bulgarian HPAI A(H5N8) viruses and not to the HPAI A(H5N8) viruses currently circulating in Europe.An increasing number of HPAI A(H5N1), A(H5N2), A(H5N5) and A(H5N6) virus outbreaks in poultry in Asia were reported during the time period for this report compared with the previous reporting period. Single outbreaks of HPAI A(H5N8) virus were notified by Saudi Arabia and South Africa. Furthermore, in contrast to the last report, HPAI virus‐positive wild birds were reported from Israel and one of the key migration areas in northern China.Two human cases due to A(H9N2) virus infection were reported during the reporting period.


相关文章

AMP发布调查结果以及改进欧盟IVDR实施的建议

纽约——分子病理学协会周二发布了其对欧盟体外诊断监管计划影响的调查结果。IVDR法规对欧洲实验室提出了统一要求,要求各机构证明其自制测试的使用合理性,同时制定规则以确保其安全和性能。AMP的调查旨在确......

欧盟列出数百种关键药物,以防止短缺

欧洲委员会、药品管理机构主管和欧洲药品管理局周二发布了一份首批包括200多种药物的清单,这些药物被认为对整个欧洲的医疗系统至关重要。关键药物是用于治疗严重疾病的药物,如果短缺的话,很难找到容易替代的药......

欧盟制定动物源性食品中酮洛芬的最大残留限量

酮洛芬是一种化学物质,呈白色结晶性粉末状;无臭或几乎无臭。在甲醇中极易溶,在乙醇、丙酮或乙醚中易溶,在水中几乎不溶。熔点约93—96℃。为芳基烷酸类化合物。具有镇痛、消炎及解热作用。消炎作用较布洛芬为......

9月各国化妆品法规动态“微塑料”相关产品将逐步退出欧洲?

随着人们对美容和护肤的需求不断增加,化妆品市场的规模也在不断扩大。全球化妆品市场的销售额逐年增长,其中护肤品、彩妆、护发产品等细分市场表现出较强的增长势头。由于化妆品直接与人体接触,因此其安全性和合法......

重磅!欧盟微塑料禁令生效,这些东西不能卖了

2023年9月25日,欧盟委员会发布公告,讨论多年的微塑料限制案于布鲁塞尔表决通过,借由对REACH法规附件十七的修改,限制微塑料本身及其相关产品在欧盟范围内的投放,从而减少微塑料对环境的污染。根据法......

抗体新药诞生,200万非小细胞肺癌患者有救了

今日,FDA官网信息显示,重磅PD-1抑制剂Keytruda已经获得美国FDA批准,与含铂化疗联用作为手术前新辅助治疗,并在手术后单药作为辅助治疗,用于治疗可切除(肿瘤≥4厘米或淋巴结阳性)的非小细胞......

10亿只月饼被欧洲退回“致癌物”又是添加剂?大瓜:为何现在被退回?

中秋佳节是个举国欢庆,阖家团圆的日子。每年中秋节都会吃的传统美食——月饼,在最近的一次出口欧洲的过程中,被欧盟拒之门外,数量达1万多吨,按一个月饼重100克算,大概是10亿只月饼被退回。 &......

欧盟重磅电池法规正式生效:谁生产谁回收、谁进口谁回收

电池在当今产业经济中发挥着至关重要的作用,它是欧盟委员会实施欧盟绿色交易、循环经济行动计划和新工业战略计划不可或缺的一部分。自2023年7月28日欧盟官方公示满20天后,新的《欧盟电池与废电池法规》(......

透视欧盟人工智能法草案

随着人工智能技术的应用和发展,人们对它可能带来的收益和风险的认识日益深刻。当下,人工智能的跳跃式发展在给人类社会带来广阔前景的同时,也给个人安全和保障带来很大风险,增加了侵犯人类基本权利的可能性。然而......

欧盟确定6种不需要审查最大残留限量的活性物质

2023年2月13日,欧盟食品安全局(EFSA)发布6种不需要审查最大残留限量的活性物质。 这6种活性物质为绿磺隆(Chlorsulfuron)、氟环唑(Epoxiconazole)、棕色绿......